CA1315689C - Derives quaternaires de la noroxymorphone soulageant la nausee et le vomissement - Google Patents

Derives quaternaires de la noroxymorphone soulageant la nausee et le vomissement

Info

Publication number
CA1315689C
CA1315689C CA000548964A CA548964A CA1315689C CA 1315689 C CA1315689 C CA 1315689C CA 000548964 A CA000548964 A CA 000548964A CA 548964 A CA548964 A CA 548964A CA 1315689 C CA1315689 C CA 1315689C
Authority
CA
Canada
Prior art keywords
administration
noroxymorphone
narcotic analgesic
morphine
emesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000548964A
Other languages
English (en)
Inventor
Leon I. Goldberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Chicago
Original Assignee
University of Chicago
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/092,470 external-priority patent/US4861781A/en
Application filed by University of Chicago filed Critical University of Chicago
Application granted granted Critical
Publication of CA1315689C publication Critical patent/CA1315689C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000548964A 1987-09-03 1987-10-09 Derives quaternaires de la noroxymorphone soulageant la nausee et le vomissement Expired - Lifetime CA1315689C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/092,470 US4861781A (en) 1986-03-07 1987-09-03 Quaternary derivatives of noroxymorphone which relieve nausea and emesis
US092,470 1987-09-03

Publications (1)

Publication Number Publication Date
CA1315689C true CA1315689C (fr) 1993-04-06

Family

ID=22233375

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000548964A Expired - Lifetime CA1315689C (fr) 1987-09-03 1987-10-09 Derives quaternaires de la noroxymorphone soulageant la nausee et le vomissement

Country Status (6)

Country Link
JP (1) JP2625457B2 (fr)
KR (1) KR890004704A (fr)
CA (1) CA1315689C (fr)
DK (1) DK167340B1 (fr)
NZ (1) NZ222911A (fr)
PH (1) PH22582A (fr)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7563899B2 (en) 2005-05-25 2009-07-21 Progenics Pharmaceuticals, Inc. (S)-N-methylnaltrexone
US7674904B2 (en) 2005-05-25 2010-03-09 Progenics Pharmaceuticals, Inc. Synthesis of R-N-methylnaltrexone
US8247425B2 (en) 2008-09-30 2012-08-21 Wyeth Peripheral opioid receptor antagonists and uses thereof
US8338446B2 (en) 2007-03-29 2012-12-25 Wyeth Llc Peripheral opioid receptor antagonists and uses thereof
US8471022B2 (en) 2008-02-06 2013-06-25 Progenics Pharmaceuticals, Inc. Preparation and use of (R),(R)-2,2′-bis-methylnaltrexone
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
US8524731B2 (en) 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8546418B2 (en) 2007-03-29 2013-10-01 Progenics Pharmaceuticals, Inc. Peripheral opioid receptor antagonists and uses thereof
US8552025B2 (en) 2003-04-08 2013-10-08 Progenics Pharmaceuticals, Inc. Stable methylnaltrexone preparation
US8685995B2 (en) 2008-03-21 2014-04-01 The University Of Chicago Treatment with opioid antagonists and mTOR inhibitors
US9102680B2 (en) 2007-03-29 2015-08-11 Wyeth Llc Crystal forms of (R)-N-methylnaltrexone bromide and uses thereof

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274591B1 (en) 1997-11-03 2001-08-14 Joseph F. Foss Use of methylnaltrexone and related compounds
US6451806B2 (en) 1999-09-29 2002-09-17 Adolor Corporation Methods and compositions involving opioids and antagonists thereof
US6469030B2 (en) 1999-11-29 2002-10-22 Adolor Corporation Methods for the treatment and prevention of ileus
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
ES2714198T3 (es) 2005-03-07 2019-05-27 Univ Chicago Uso de antagonistas opioideos para atenuar la proliferación y la migración de células endoteliales
US20090292124A1 (en) * 2005-10-11 2009-11-26 Toray Industries, Inc. A Corporation Of Japan Therapeutic Agent for Nausea and/or Vomiting
KR101519682B1 (ko) * 2007-08-09 2015-05-19 렌슬러 폴리테크닉 인스티튜트 4급 오피오이드 카르복스아미드

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10376584B2 (en) 2003-04-08 2019-08-13 Progenics Pharmaceuticals, Inc. Stable pharmaceutical formulations of methylnaltrexone
US9669096B2 (en) 2003-04-08 2017-06-06 Progenics Pharmaceuticals, Inc. Stable pharmaceutical formulations of methylnaltrexone
US8552025B2 (en) 2003-04-08 2013-10-08 Progenics Pharmaceuticals, Inc. Stable methylnaltrexone preparation
US8524731B2 (en) 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
US8343992B2 (en) 2005-05-25 2013-01-01 Progenics Pharmaceuticals, Inc. Synthesis of R-N-methylnaltrexone
US8916581B2 (en) 2005-05-25 2014-12-23 Progenics Pharmaceuticals, Inc. (S)-N-methylnaltrexone
US7563899B2 (en) 2005-05-25 2009-07-21 Progenics Pharmaceuticals, Inc. (S)-N-methylnaltrexone
US9597327B2 (en) 2005-05-25 2017-03-21 Progenics Pharmaceuticals, Inc. Synthesis of (R)-N-methylnaltrexone
US7674904B2 (en) 2005-05-25 2010-03-09 Progenics Pharmaceuticals, Inc. Synthesis of R-N-methylnaltrexone
US8003794B2 (en) 2005-05-25 2011-08-23 Progenics Pharmaceuticals, Inc. (S)-N-methylnaltrexone
US8338446B2 (en) 2007-03-29 2012-12-25 Wyeth Llc Peripheral opioid receptor antagonists and uses thereof
US8546418B2 (en) 2007-03-29 2013-10-01 Progenics Pharmaceuticals, Inc. Peripheral opioid receptor antagonists and uses thereof
US9102680B2 (en) 2007-03-29 2015-08-11 Wyeth Llc Crystal forms of (R)-N-methylnaltrexone bromide and uses thereof
US8772310B2 (en) 2007-03-29 2014-07-08 Wyeth Llc Peripheral opioid receptor antagonists and uses thereof
US9879024B2 (en) 2007-03-29 2018-01-30 Progenics Pharmaceuticals., Inc. Crystal forms of (R)-N-methylnaltrexone bromide and uses thereof
US8853232B2 (en) 2007-03-29 2014-10-07 Wyeth Llc Peripheral opioid receptor antagonists and uses thereof
US8916706B2 (en) 2008-02-06 2014-12-23 Progenics Pharmaceuticals, Inc. Preparation and use of (R),(R)-2,2′-bis-methylnaltrexone
US8471022B2 (en) 2008-02-06 2013-06-25 Progenics Pharmaceuticals, Inc. Preparation and use of (R),(R)-2,2′-bis-methylnaltrexone
US9526723B2 (en) 2008-03-21 2016-12-27 The University Of Chicago Treatment with opioid antagonists and mTOR inhibitors
US8685995B2 (en) 2008-03-21 2014-04-01 The University Of Chicago Treatment with opioid antagonists and mTOR inhibitors
US10383869B2 (en) 2008-03-21 2019-08-20 The University Of Chicago Treatment with opioid antagonists and mTOR inhibitors
US8455644B2 (en) 2008-09-30 2013-06-04 Wyeth Peripheral opioid receptor antagonists and uses thereof
US9492445B2 (en) 2008-09-30 2016-11-15 Wyeth, Llc Peripheral opioid receptor antagonists and uses thereof
US9180125B2 (en) 2008-09-30 2015-11-10 Wyeth, Llc Peripheral opioid receptor antagonists and uses thereof
US9724343B2 (en) 2008-09-30 2017-08-08 Wyeth, Llc Peripheral opioid receptor antagonists and uses thereof
US8822490B2 (en) 2008-09-30 2014-09-02 Wyeth Llc Peripheral opioid receptor antagonists and uses thereof
US8420663B2 (en) 2008-09-30 2013-04-16 Wyeth Peripheral opioid receptor antagonists and uses thereof
US8247425B2 (en) 2008-09-30 2012-08-21 Wyeth Peripheral opioid receptor antagonists and uses thereof

Also Published As

Publication number Publication date
KR890004704A (ko) 1989-05-09
JPS6468376A (en) 1989-03-14
DK693387D0 (da) 1987-12-30
NZ222911A (en) 1990-11-27
DK693387A (da) 1989-03-04
PH22582A (en) 1988-10-17
JP2625457B2 (ja) 1997-07-02
DK167340B1 (da) 1993-10-18

Similar Documents

Publication Publication Date Title
US4861781A (en) Quaternary derivatives of noroxymorphone which relieve nausea and emesis
US4719215A (en) Quaternary derivatives of noroxymorphone which relieve nausea and emesis
CA1315689C (fr) Derives quaternaires de la noroxymorphone soulageant la nausee et le vomissement
US5102887A (en) Method for reducing emesis and nausea induced by the administration of an emesis causing agent
DE69634609T2 (de) Analgesische synergie durch gleichzeitige verabreichung von subanalgesischen dosen eines mu-opioid agonisten und eines kappa - 2- opioi agonisten
EP0306575B1 (fr) Dérivés quaternaires de noroxymorphone pour le traitement de nausée et d'émèse
CA1200501A (fr) Nalbuphene - analgesique stupefiant et methode de production de l'analgesie
EP0980247A1 (fr) Composition et methode associant un antidepresseur et un antagoniste de recepteur nmda pour traiter la douleur neuropathique
Petersen et al. Chronic pain treatment with intravenous lidocaine
MX2010011727A (es) Administracion oral de antagonistas opioides que actuan perifericamente.
PT1096936E (pt) Tratamento da discinesia
EP0514023B1 (fr) Utilisation de ligands du récepteur glycine/NMDA pour la fabrication d'un médicament pour le traitement de la dépendence aux drogues et du symptone d'abstinence
US5935944A (en) Formulation for I.V. administration of the boron delivery drug, boronophenylalanine (BPA)
EP0681838A1 (fr) Composition officinale analgesique
AU684711B2 (en) Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine for the treatment of pain and oedema
SK280111B6 (sk) Použitie ropivakaínu na výrobu farmaceutického pro
Dubois et al. Prevention and treatment of the gastric symptoms of radiation sickness
US4829068A (en) Treatment of disorders of the gastro-intestinal tract
AU2002216029A1 (en) A combination comprising camptothecin and a stilbene derivative for the treatment of cancer
EP1333820A2 (fr) Combinaison de camptothecine et d'un derive de stilbene pour le traitement du cancer
KR930702985A (ko) 식도암의 치료
US4575506A (en) Method of treatment for inhibiting the tolerance onset while treating painful syndromes with central analgesics
GB2189703A (en) Vinpocetine
DE69816790T2 (de) Verbesserung der opioid-toleranz durch hemmung der induzierbaren stickstoffoxid-synthase zur behandlung von schmerzen
US20090270401A1 (en) Use of a dihydroimidazopyrazoine derivative for treating or preventing pain

Legal Events

Date Code Title Description
MKEX Expiry